ARGENX SE is 18.5x more valuable than Beam Therapeutics Inc. by market capitalization ($55.29 B vs $2.99 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BEAM | ARGX |
|---|---|---|
| Market cap | $2.99 B | $55.29 B |
| US-listed rank | #1828 | #303 |
| Revenue (latest FY) | $139.74M | - |
| Net income (latest FY) | -$79.99M | - |
| Net margin | -57.2% | - |
| SEC filings | 488 | 272 |
ARGENX SE is 18.5x more valuable than Beam Therapeutics Inc. by market capitalization ($55.29 B vs $2.99 B).
Full pages: Beam Therapeutics Inc. and ARGENX SE, or browse the full rankings.